vs
Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $14.6M, roughly 1.3× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -3.0%, a 67.3% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs -25.6%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $2.2M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs -10.1%).
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
IDR vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $18.3M |
| Net Profit | $9.4M | $-554.0K |
| Gross Margin | 68.5% | 21.1% |
| Operating Margin | 62.4% | -2.2% |
| Net Margin | 64.3% | -3.0% |
| Revenue YoY | 92.0% | -25.6% |
| Net Profit YoY | 220.6% | 26.7% |
| EPS (diluted) | $0.62 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.6M | $18.3M | ||
| Q3 25 | $11.1M | $15.9M | ||
| Q2 25 | $9.5M | $16.1M | ||
| Q1 25 | $7.3M | $18.9M | ||
| Q4 24 | $7.6M | $24.7M | ||
| Q3 24 | $6.2M | $28.3M | ||
| Q2 24 | $6.1M | $25.8M | ||
| Q1 24 | $5.9M | $22.7M |
| Q4 25 | $9.4M | $-554.0K | ||
| Q3 25 | $3.0M | $-1.8M | ||
| Q2 25 | $2.8M | $-1.5M | ||
| Q1 25 | $1.6M | $-1.5M | ||
| Q4 24 | $2.9M | $-756.0K | ||
| Q3 24 | $1.6M | $1.7M | ||
| Q2 24 | $2.2M | $343.0K | ||
| Q1 24 | $2.2M | $-1.7M |
| Q4 25 | 68.5% | 21.1% | ||
| Q3 25 | 63.6% | 14.3% | ||
| Q2 25 | 57.8% | 15.6% | ||
| Q1 25 | 50.8% | 16.1% | ||
| Q4 24 | 53.3% | 14.7% | ||
| Q3 24 | 48.7% | 22.0% | ||
| Q2 24 | 50.2% | 17.6% | ||
| Q1 24 | 48.1% | 13.5% |
| Q4 25 | 62.4% | -2.2% | ||
| Q3 25 | 23.4% | -9.9% | ||
| Q2 25 | 26.6% | -8.4% | ||
| Q1 25 | 19.3% | -7.2% | ||
| Q4 24 | 36.2% | -2.1% | ||
| Q3 24 | 23.4% | 6.8% | ||
| Q2 24 | 34.2% | 2.0% | ||
| Q1 24 | 36.3% | -5.8% |
| Q4 25 | 64.3% | -3.0% | ||
| Q3 25 | 26.8% | -11.0% | ||
| Q2 25 | 29.2% | -9.3% | ||
| Q1 25 | 22.1% | -8.0% | ||
| Q4 24 | 38.5% | -3.1% | ||
| Q3 24 | 25.8% | 5.9% | ||
| Q2 24 | 35.2% | 1.3% | ||
| Q1 24 | 36.8% | -7.6% |
| Q4 25 | $0.62 | $-0.01 | ||
| Q3 25 | $0.20 | $-0.05 | ||
| Q2 25 | $0.20 | $-0.05 | ||
| Q1 25 | $0.12 | $-0.04 | ||
| Q4 24 | $0.21 | $-0.02 | ||
| Q3 24 | $0.12 | $0.04 | ||
| Q2 24 | $0.17 | $0.01 | ||
| Q1 24 | $0.17 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | $2.3M | — |
| Stockholders' EquityBook value | $108.2M | $37.0M |
| Total Assets | $116.2M | $57.1M |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | $6.3M | $11.9M | ||
| Q1 24 | $5.3M | $6.6M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $3.3M | — |
| Q4 25 | $108.2M | $37.0M | ||
| Q3 25 | $74.3M | $37.0M | ||
| Q2 25 | $49.3M | $30.4M | ||
| Q1 25 | $39.8M | $31.5M | ||
| Q4 24 | $37.7M | $32.6M | ||
| Q3 24 | $33.1M | $29.1M | ||
| Q2 24 | $25.4M | $23.5M | ||
| Q1 24 | $21.6M | $20.6M |
| Q4 25 | $116.2M | $57.1M | ||
| Q3 25 | $83.1M | $57.5M | ||
| Q2 25 | $57.7M | $52.6M | ||
| Q1 25 | $48.1M | $54.0M | ||
| Q4 24 | $44.0M | $59.2M | ||
| Q3 24 | $40.8M | $57.1M | ||
| Q2 24 | $32.2M | $53.0M | ||
| Q1 24 | $28.7M | $50.7M |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.7M | $2.3M |
| Free Cash FlowOCF − Capex | $8.2M | $2.2M |
| FCF MarginFCF / Revenue | 56.0% | 12.0% |
| Capex IntensityCapex / Revenue | 17.7% | 0.5% |
| Cash ConversionOCF / Net Profit | 1.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.4M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | $2.3M | ||
| Q3 25 | $2.4M | $-1.3M | ||
| Q2 25 | $3.5M | $1.8M | ||
| Q1 25 | $2.4M | $-3.5M | ||
| Q4 24 | $3.2M | $865.0K | ||
| Q3 24 | $2.5M | $4.3M | ||
| Q2 24 | $2.6M | $1.4M | ||
| Q1 24 | $2.6M | $-2.4M |
| Q4 25 | $8.2M | $2.2M | ||
| Q3 25 | $709.8K | $-1.5M | ||
| Q2 25 | $2.5M | $1.7M | ||
| Q1 25 | $1.0M | $-3.5M | ||
| Q4 24 | $2.1M | $470.0K | ||
| Q3 24 | $1.9M | $4.1M | ||
| Q2 24 | $2.4M | $1.2M | ||
| Q1 24 | $2.3M | $-2.5M |
| Q4 25 | 56.0% | 12.0% | ||
| Q3 25 | 6.4% | -9.6% | ||
| Q2 25 | 26.5% | 10.5% | ||
| Q1 25 | 13.8% | -18.8% | ||
| Q4 24 | 28.0% | 1.9% | ||
| Q3 24 | 30.4% | 14.4% | ||
| Q2 24 | 38.7% | 4.5% | ||
| Q1 24 | 38.3% | -11.1% |
| Q4 25 | 17.7% | 0.5% | ||
| Q3 25 | 15.3% | 1.4% | ||
| Q2 25 | 10.8% | 1.0% | ||
| Q1 25 | 19.4% | 0.3% | ||
| Q4 24 | 13.6% | 1.6% | ||
| Q3 24 | 9.8% | 0.7% | ||
| Q2 24 | 4.3% | 1.1% | ||
| Q1 24 | 5.5% | 0.6% |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.56× | 2.57× | ||
| Q2 24 | 1.22× | 4.20× | ||
| Q1 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDR
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
